A Comparison of Esmolol and Remifentanil to Reduce Blood Loss

• Status: Unknown status
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

In this prospective randomized study we aimed to compare the effects of esmolol and remifentanil on intraoperative bleeding surgical field conditions in nasal surgery

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Diskapi Teaching and Research Hospital
• Treatments: Esmolol; Remifentanil

Criteria

Inclusion Criteria:

• ASA I-II,

• between age 20-60

Exclusion Criteria:

• patients having bleeding disorders,

• arrhythmia,

• hypertension,

• endocrine, liver or kidney disease and

• those who are on antihypertensive,

• anticoagulant drugs